One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates

SC Rao, R Srinivasjois, K Moon - Cochrane database of …, 2016 - cochranelibrary.com
Background Animal studies and trials in older children and adults suggest that a'one dose
per day'regimen of gentamicin is superior to a'multiple doses per day'regimen. Objectives To …

Clinical pharmacokinetics of gentamicin in various patient populations and consequences for optimal dosing for gram-negative infections: an updated review

CJ Hodiamont, AK van den Broek, SL de Vroom… - Clinical …, 2022 - Springer
Gentamicin is an aminoglycoside antibiotic with a small therapeutic window that is currently
used primarily as part of short-term empirical combination therapy. Gentamicin dosing …

Scaling clearance in paediatric pharmacokinetics: all models are wrong, which are useful?

E Germovsek, CIS Barker, M Sharland… - British journal of …, 2017 - Wiley Online Library
Linked Articles This article is commented on in the editorial by Holford NHG and Anderson
BJ. Why standards are useful for predicting doses. Br J Clin Pharmacol 2017; 83: 685–7. doi …

Does “birth” as an event impact maturation trajectory of renal clearance via glomerular filtration? Reexamining data in preterm and full‐term neonates by avoiding the …

F Salem, TN Johnson, ABJ Hodgkinson… - The Journal of …, 2021 - Wiley Online Library
Glomerular filtration rate (GFR) is an important measure of renal function. Various models for
its maturation have recently been compared; however, these have used markers, which are …

Pharmacometric approaches to personalize use of primarily renally eliminated antibiotics in preterm and term neonates

M Wilbaux, A Fuchs, J Samardzic… - The Journal of …, 2016 - Wiley Online Library
Sepsis remains a major cause of mortality and morbidity in neonates, and, as a
consequence, antibiotics are the most frequently prescribed drugs in this vulnerable patient …

Preterm physiologically based pharmacokinetic model. Part II: applications of the model to predict drug pharmacokinetics in the preterm population

K Abduljalil, X Pan, A Pansari, M Jamei… - Clinical …, 2020 - Springer
Background Preterm neonates are usually not part of a traditional drug development
programme, however they are frequently administered medicines. Developing modelling …

A preterm physiologically based pharmacokinetic model. Part I: physiological parameters and model building

K Abduljalil, X Pan, A Pansari, M Jamei… - Clinical …, 2020 - Springer
Background Developmental physiology can alter pharmacotherapy in preterm populations.
Because of ethical and clinical constraints in studying this vulnerable age group …

The blind spot of pharmacology: a scoping review of drug metabolism in prematurely born children

ML Mørk, JT Andersen, U Lausten-Thomsen… - Frontiers in …, 2022 - frontiersin.org
The limit for possible survival after extremely preterm birth has steadily improved and
consequently, more premature neonates with increasingly lower gestational age at birth now …

Use of antibiotics in preterm newborns

R Simeoli, S Cairoli, N Decembrino, F Campi… - Antibiotics, 2022 - mdpi.com
Due to complex maturational and physiological changes that characterize neonates and
affect their response to pharmacological treatments, neonatal pharmacology is different from …

Development and evaluation of a gentamicin pharmacokinetic model that facilitates opportunistic gentamicin therapeutic drug monitoring in neonates and infants

E Germovsek, A Kent, T Metsvaht, I Lutsar… - Antimicrobial agents …, 2016 - Am Soc Microbiol
Trough gentamicin therapeutic drug monitoring (TDM) is time-consuming, disruptive to
neonatal clinical care, and a patient safety issue. Bayesian models could allow TDM to be …